The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Brazilian footwear to join Saudi fashion week
- Brazil to discuss critical minerals at BRICS, G7
- Qatar opens entries for global education prize
- Brazil exports to Arab countries up 3.1% in April
- Gustavo Castro film portrays Palestine
- Saudi Aramco expands profit by 25%
- Workshop brings halal concept to Tourism Expo
- Pope Leo XIV receives Sudan’s prime minister
